» Articles » PMID: 25350374

Independent Relationship Between Amyloid Precursor Protein (APP) Dimerization and γ-secretase Processivity

Overview
Journal PLoS One
Date 2014 Oct 29
PMID 25350374
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Altered production of β-amyloid (Aβ) from the amyloid precursor protein (APP) is closely associated with Alzheimer's disease (AD). APP has a number of homo- and hetero-dimerizing domains, and studies have suggested that dimerization of β-secretase derived APP carboxyl terminal fragment (CTFβ, C99) impairs processive cleavage by γ-secretase increasing production of long Aβs (e.g., Aβ1-42, 43). Other studies report that APP CTFβ dimers are not γ-secretase substrates. We revisited this issue due to observations made with an artificial APP mutant referred to as 3xK-APP, which contains three lysine residues at the border of the APP ectodomain and transmembrane domain (TMD). This mutant, which dramatically increases production of long Aβ, was found to form SDS-stable APP dimers, once again suggesting a mechanistic link between dimerization and increased production of long Aβ. To further evaluate how multimerization of substrate affects both initial γ-secretase cleavage and subsequent processivity, we generated recombinant wild type- (WT) and 3xK-C100 substrates, isolated monomeric, dimeric and trimeric forms of these proteins, and evaluated both ε-cleavage site utilization and Aβ production. These show that multimerization significantly impedes γ-secretase cleavage, irrespective of substrate sequence. Further, the monomeric form of the 3xK-C100 mutant increased long Aβ production without altering the initial ε-cleavage utilization. These data confirm and extend previous studies showing that dimeric substrates are not efficient γ-secretase substrates, and demonstrate that primary sequence determinants within APP substrate alter γ-secretase processivity.

Citing Articles

Cholesterol-dependent amyloid β production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol.

Rudajev V, Novotny J Cell Biosci. 2023; 13(1):171.

PMID: 37705117 PMC: 10500844. DOI: 10.1186/s13578-023-01127-y.


APP family member dimeric complexes are formed predominantly in synaptic compartments.

Schilling S, August A, Meleux M, Conradt C, Tremmel L, Teigler S Cell Biosci. 2023; 13(1):141.

PMID: 37533067 PMC: 10398996. DOI: 10.1186/s13578-023-01092-6.


An internal docking site stabilizes substrate binding to γ-secretase: Analysis by molecular dynamics simulations.

Chen S, Zacharias M Biophys J. 2022; 121(12):2330-2344.

PMID: 35598043 PMC: 9279352. DOI: 10.1016/j.bpj.2022.05.023.


Aß40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aß42 toxicity in Drosophila.

de Mena L, Smith M, Martin J, Dunton K, Ceballos-Diaz C, Jansen-West K Alzheimers Res Ther. 2020; 12(1):132.

PMID: 33069251 PMC: 7568834. DOI: 10.1186/s13195-020-00698-z.


Bicelles Rich in both Sphingolipids and Cholesterol and Their Use in Studies of Membrane Proteins.

Hutchison J, Shih K, Scheidt H, Fantin S, Parson K, Pantelopulos G J Am Chem Soc. 2020; 142(29):12715-12729.

PMID: 32575981 PMC: 7924963. DOI: 10.1021/jacs.0c04669.


References
1.
McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C . Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005; 47(2):191-199. PMC: 1373682. DOI: 10.1016/j.neuron.2005.06.030. View

2.
Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima-Kawashima M, Funamoto S . gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci. 2009; 29(41):13042-52. PMC: 6665297. DOI: 10.1523/JNEUROSCI.2362-09.2009. View

3.
Jung J, Ran Y, Cruz P, Rosario A, Ladd T, Kukar T . Complex relationships between substrate sequence and sensitivity to alterations in γ-secretase processivity induced by γ-secretase modulators. Biochemistry. 2014; 53(12):1947-57. PMC: 3985764. DOI: 10.1021/bi401521t. View

4.
Murayama O, Tomita T, Nihonmatsu N, Murayama M, Sun X, Honda T . Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease. Neurosci Lett. 1999; 265(1):61-3. DOI: 10.1016/s0304-3940(99)00187-1. View

5.
Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N . Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med. 1996; 2(8):864-70. DOI: 10.1038/nm0896-864. View